. "Appendix E: Drugs Used in the Treatment of MS." Multiple Sclerosis: Current Status and Strategies for the Future. Washington, DC: The National Academies Press, 2001.
The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Page 399
aClinical trial phases are defined at the end of this table.
bThe PhRMA (Pharmaceutical Research and Manufacturers of America) Database lists only clinical trials being conducted in private firms in the U.S. Clinical trials at academic health centers and universities are not included.
chttp://mscenter.ucsf.edu dListed as an orphan drug by FDA, http://www.fda.gov/orphan.
e The ClinicalTrials.gov Database contains clinical studies sponsored primarily by the National Institutes of Health. In the future, additional studies from other Federal agencies and the pharmaceutical industry will be included.
